(Applied Clinical Trials Blog, Philip Ward) It’s probably fair to say that the European Patients’ Academy on Therapeutic Innovation (EUPATI) has made a rather slow start since its launch on February 1. There doesn’t seem to have been a huge blaze of publicity or a massive wave enthusiasm for the new group, which has so far amassed a mere 13 followers on Facebook. So what’s EUPATI about, and should we be interested in it? According to its website, over the next five years this patient-led academy will develop (...) Continue reading